IRONWOOD PHARMACEUTICALS, INC. Accrued Income Taxes, Current
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Accrued Income Taxes, Current of $4.28 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2026-08-06
- 2026-06-30: Accrued Income Taxes, Current $4.28M.
- 2026-03-31: Accrued Income Taxes, Current $3.89M.
- 2025-12-31: Accrued Income Taxes, Current $927.00K.
- 2025-09-30: Accrued Income Taxes, Current $656.00K.
| Period end | Accrued Income Taxes, Current |
|---|---|
| 2026-06-30 | $4.28M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $3.89M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $927.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $656.00K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $764.00K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $721.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $521.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $986.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $935.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.90M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $1.24M 10-K · filed 2025-03-31 |
| 2023-09-30 | $1.27M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $6.65M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $2.70M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $656.00K 10-K · filed 2024-02-16 |
| 2022-06-30 | $200.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $300.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $200.00K 10-Q · filed 2022-08-04 |
| 2021-09-30 | $500.00K 10-Q · filed 2021-11-04 |
| 2021-03-31 | $300.00K 10-Q · filed 2021-05-06 |
| 2020-09-30 | $1.39M 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |